Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B reforms). 21st century cures 2.0 legislation.
Source-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FARRAGUT PARTNERS LLP
- Client
- GENENTECH
- Filing UUID
- 4f04f9d2-b00e-47f9-8868-5c128684aef9
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the 340B Drug discount program. Drug Pricing Proposals. Issues related to drug pricing. 21st century cures 2.0 legislation.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.